Lazard agreed to acquire Campbell Lutyens for $575 million in cash and equity, announced Tuesday morning. The London-founded firm advises GPs on fundraising and LPs on secondaries across $150 billion in annual transaction volume. Lazard will fold the 180-person team into a new Private Capital Advisory segment, its first dedicated alternatives-focused business line since restructuring in 2022.

Campbell Lutyens generated $185 million in revenue over the trailing twelve months with 32% EBITDA margins. The firm has raised capital for 420 private equity and infrastructure funds since inception and operates secondaries advisory across both GP-led and LP portfolio transactions. Lazard will pay 60% cash at close and the remainder in restricted stock vesting over three years. The deal values Campbell Lutyens at roughly 3.1x revenue, below Evercore's 4.2x trailing multiple but above Moelis at 2.8x. Campbell Lutyens founder Alistair Robinson and the senior partnership will remain through earnout provisions tied to 2026 and 2027 revenue targets.

This is infrastructure arbitrage. Lazard has $8.2 billion in advisory revenue but minimal exposure to the private capital formation cycle that now commands $13 trillion in global AUM. Campbell Lutyens provides immediate access to 1,200 LP relationships and 300 GP clients across secondaries, continuation vehicles, and direct co-investment structuring. The secondaries market alone crossed $130 billion in volume last year, up 22% from 2023, with GP-led transactions accounting for 60% of deal flow. Lazard lacked a seat at that table. It now owns one of three firms globally with integrated GP fundraising and LP secondaries advisory under one P&L.

The timing reflects allocation pressure. Institutional LPs are overweight private equity after a decade of denominator drift and underweight public equities after the 2023-2024 rally. That creates structural bid for secondaries as a rebalancing tool and raises the stakes for funds seeking LP commitments in a capital-constrained environment. Lazard's M&A advisory backlog has compressed 18% year-over-year as sponsors delay exits. Private capital advisory generates counter-cyclical revenue during M&A droughts and creates deal flow visibility eighteen months ahead of transaction closings. The segment also carries 200 basis points higher margins than traditional M&A advisory due to retainer-based fee structures and lower cost-to-serve.

Allocators should track Lazard's ability to cross-sell restructuring and M&A services into Campbell Lutyens' GP client base. The firm has 90 active restructuring mandates, many involving sponsor-backed portfolio companies navigating refinancing walls in 2025 and 2026. Secondaries advisory creates early visibility into distressed fund positions before they hit the market. Lazard will also compete directly with Evercore, which has grown private capital advisory revenue 340% since 2019 and now books $420 million annually in that segment. The deal closes in Q2 2025 subject to UK regulatory approval.

Lazard's stock traded down 1.8% on Tuesday to $48.23, suggesting the market is pricing integration risk rather than the thirty-six-month revenue synergy case. The firm will consolidate Campbell Lutyens' results beginning in Q3 2025 reporting.